Shares of CompoSecure, Inc. (NASDAQ:CMPO - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $16.1875.
Several brokerages have issued reports on CMPO. Wall Street Zen downgraded shares of CompoSecure from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. Needham & Company LLC reissued a "buy" rating and set a $15.00 price objective on shares of CompoSecure in a research report on Tuesday, May 13th.
Read Our Latest Stock Analysis on CMPO
Institutional Trading of CompoSecure
Several hedge funds have recently made changes to their positions in CMPO. GAMMA Investing LLC lifted its stake in shares of CompoSecure by 1,524.4% in the first quarter. GAMMA Investing LLC now owns 2,794 shares of the company's stock valued at $30,000 after purchasing an additional 2,622 shares during the period. MorganRosel Wealth Management LLC acquired a new stake in shares of CompoSecure in the first quarter valued at about $43,000. AlphaQuest LLC acquired a new stake in shares of CompoSecure in the first quarter valued at about $72,000. KLP Kapitalforvaltning AS acquired a new stake in shares of CompoSecure in the fourth quarter valued at about $75,000. Finally, Summit Securities Group LLC acquired a new stake in shares of CompoSecure in the first quarter valued at about $107,000. Institutional investors and hedge funds own 37.56% of the company's stock.
CompoSecure Stock Up 1.4%
CompoSecure stock traded up $0.19 during mid-day trading on Friday, reaching $14.06. 172,390 shares of the company's stock were exchanged, compared to its average volume of 909,177. The company has a market cap of $1.44 billion, a P/E ratio of -12.78 and a beta of 0.94. CompoSecure has a twelve month low of $7.32 and a twelve month high of $17.71. The company has a fifty day moving average of $14.16 and a 200-day moving average of $13.18.
CompoSecure (NASDAQ:CMPO - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.25 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.06. The firm had revenue of $103.90 million for the quarter, compared to the consensus estimate of $103.22 million. CompoSecure had a negative net margin of 15.36% and a negative return on equity of 33.46%. Equities research analysts expect that CompoSecure will post 1.02 earnings per share for the current fiscal year.
About CompoSecure
(
Get Free Report)
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
Read More

Before you consider CompoSecure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.
While CompoSecure currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.